litlas
Log inCreate account

Peter Dreger

Active 1993–2025

199
Papers
18,752
Citations
83
h-index
191
i10-index

Citations

Citations per year for Peter Dreger1993: 2 citations1994: 6 citations1995: 19 citations1996: 25 citations1997: 36 citations1998: 23 citations1999: 39 citations2000: 43 citations2001: 23 citations2002: 31 citations2003: 25 citations2004: 34 citations2005: 55 citations2006: 34 citations2007: 36 citations2008: 54 citations2009: 53 citations2010: 59 citations2011: 64 citations2012: 76 citations2013: 72 citations2014: 95 citations2015: 117 citations2016: 127 citations2017: 101 citations2018: 117 citations2019: 423 citations2020: 544 citations2021: 530 citations2022: 504 citations2023: 446 citations2024: 846 citations2025: 457 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,639 citing papers, 19% of this breakdownGermany: 913 citing papers, 10.6% of this breakdownItaly: 607 citing papers, 7% of this breakdownUnited Kingdom: 599 citing papers, 6.9% of this breakdownFrance: 548 citing papers, 6.4% of this breakdownChina: 463 citing papers, 5.4% of this breakdownSpain: 432 citing papers, 5% of this breakdownNetherlands: 347 citing papers, 4% of this breakdownSwitzerland: 245 citing papers, 2.8% of this breakdownCanada: 232 citing papers, 2.7% of this breakdownIsrael: 193 citing papers, 2.2% of this breakdownAustralia: 185 citing papers, 2.2% of this breakdown
0%19%Other 25.8%

Institutions

Fields

  • Medicine82.9%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Immunology and Microbiology5.3%
  • Neuroscience1.7%
  • Psychology1%
  • Computer Science0.6%
  • Other1%

Topics

  • CAR-T cell therapy research9.2%
  • Hematopoietic Stem Cell Transplantation8.9%
  • Lymphoma Diagnosis and Treatment6.5%
  • Acute Myeloid Leukemia Research5.2%
  • Chronic Lymphocytic Leukemia Research4.7%
  • Immune Cell Function and Interaction3.2%
  • Other62.3%

Coauthors

All papers

Open in search
  1. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

    Authors: Maria‐Luisa Schubert, Michael Schmitt, L. Wang, Carlos A. Ramos, Karin Jordan, Carsten Müller‐Tidow, Peter Dreger - Annals of Oncology 2020 cited by 487

  2. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

    Authors: Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Matthias Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia‐Chi Chang, Lauren McDaniel, Ivonne I. Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphaël Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Michael Wang, Joel G. Turner, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller‐Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav - Nature Medicine 2023 cited by 226

  3. GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

    Authors: Wolfgang Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Wagner-Drouet, Gerald Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glaß, Claudia D. Baldus, Vladan Vučinić, Dimitrios Mougiakakos, Max S. Topp, Matthias Fante, Roland Schroers, Lâle M. Bayir, Peter Borchmann, Veit Buecklein, Christine Hanoun, Simone Thomas, Dietrich W. Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger - Blood 2022 cited by 211

  4. Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis

    Authors: Wolfgang Merkt, Merle Freitag, Maren Claus, Philipp Kolb, Valeria Falcone, Manuel Röhrich, Lea Rodon, Franca Sophie Deicher, Ivana Andreeva, Theresa Tretter, Lars‐Oliver Tykocinski, Norbert Blank, Carsten Watzl, Anita Schmitt, Tim Sauer, Carsten Müller‐Tidow, Markus Polke, Claus Peter Heußel, Peter Dreger, Hanns‐Martin Lorenz, Michael Schmitt - Annals of the Rheumatic Diseases 2023 cited by 120

  5. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

    Authors: Frederick L. Locke, Simone Filosto, Justin Chou, Saran Vardhanabhuti, Régis Perbost, Peter Dreger, Brian T. Hill, Catherine J. Lee, Pier Luigi Zinzani, Nicolaus Kröger, Armando López‐Guillermo, Hildegard Greinix, Wangshu Zhang, Gayatri Tiwari, Justin A. Budka, Francesco M. Marincola, Christina To, Mike Mattie, Marco Schupp, Paul Cheng, Adrian Bot, Rhine R. Shen, Davide Bedognetti, Harry Miao, Jérôme Galon - Nature Medicine 2024 cited by 108

  6. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis

    Authors: Thomas Luft, Axel Benner, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Ted Gooley, Brenda M. Sandmaier, Natália Becker, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - The Lancet Haematology 2017 cited by 246

  7. EASIX and mortality after allogeneic stem cell transplantation

    Authors: Thomas Luft, Axel Benner, Tobias Terzer, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Lambros Kordelas, Dietrich W. Beelen, Ted Gooley, Brenda M. Sandmaier, Mohamed L. Sorror, Markus Zeisbrich, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - Bone Marrow Transplantation 2019 cited by 160

  8. Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    Authors: H. Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Othman Al‐Sawaf, Karl‐Anton Kreuzer, Anna‐Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer - Blood 2023 cited by 48

  9. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Authors: for the European Society for Blood and Marrow Transplantation (EBMT), Rafael F. Duarte, Myriam Labopin, Peter Bader, Grzegorz Basak, Chiara Bonini, Christian Chabannon, Selim Corbacioglu, Peter Dreger, Carlo Dufour, Andrew R. Gennery, Jürgen Kuball, Arjan C. Lankester, Francesco Lanza, Silvia Montoto, Arnon Nagler, Régis Peffault de Latour, John A. Snowden, Jan Styczyński, Ibrahim Yakoub‐Agha, Nicolaus Kröger, Mohamad Mohty - Bone Marrow Transplantation 2019 cited by 332

  10. Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

    Authors: Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke, Uwe Platzbecker, Ruzena Uddin, Kai Hübel, Christof Scheid, Thomas Weber, Marie Robin, Matthias Stelljes, Boris V. Afanasyev, Dominik Heim, Giorgio La Nasa, Francesco Onida, Peter Dreger, Massimo Pini, Stefano Guidi, Liisa Volin, Andreas Guenther, Wolfgang Bethge, Xavier Poiré, Guido Kobbe, Marleen van Os, Ronald Brand, Théo de Witte - Journal of Clinical Oncology 2017 cited by 249

  11. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study

    Authors: Nico Gagelmann, Gerald Wulf, Johannes Duell, Bertram Glaß, Pearl van Heteren, Bastian von Tresckow, Monika Fischer, Olaf Penack, Francis Ayuk, H. Einsele, Udo Holtick, Julia Thomson, Peter Dreger, Nicolaus Kröger - Blood Advances 2022 cited by 55

  12. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    Authors: Mahmoud Elsawy, Julio C. Chávez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martı́n, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thiéblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei‐Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten - Blood 2022 cited by 75

  13. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

    Authors: Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes, Christoph Groth, Tamás Masszi, Péter Reményi, Eva Wagner-Drouet, Beate Hauptrock, Peter Dreger, Thomas Luft, Wolfgang Bethge, Wichard Vogel, Fabio Ciceri, Jacopo Peccatori, Friedrich Stölzel, Johannes Schetelig, Christian Junghanß, Christina Große-Thie, Mauricette Michallet, Hélène Labussière‐Wallet, Kerstin Schaefer‐Eckart, Sabine Dressler, Goetz Ulrich Grigoleit, Stephan Mielke, Christof Scheid, Udo Holtick, Francesca Patriarca, Marta Medeot, Alessandro Rambaldi, Maria Caterina Micò, Dietger Niederwieser, Georg‐Nikolaus Franke, Inken Hilgendorf, Nils Winkelmann, Domenico Russo, Gèrard Socié, Régis Peffault de Latour, Ernst Holler, Daniel Wolff, Bertram Glaß, Jochen Casper, Gerald Wulf, H Menzel, Nadežda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Sandra Graß, Anna Paola Iori, Jürgen Finke, Fabio Benedetti, Uwe Pichlmeier, Claudia Hemmelmann, Michael Tribanek, Anja Klein, H. A. Mylius, Joachim Baumgart, Monika Dzierżak‐Mietła, Mirosław Markiewicz - The Lancet Haematology 2019 cited by 154

  14. EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study

    Authors: Felix Korell, Olaf Penack, Mike Mattie, Nicholas Schreck, Axel Benner, Julia Krzykalla, Zixing Wang, Michael Schmitt, Lars Bullinger, Carsten Müller‐Tidow, Peter Dreger, Thomas Luft - Frontiers in Immunology 2022 cited by 65

  15. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation

    Authors: Thomas Luft, Peter Dreger, Aleksandar Radujkovic - Bone Marrow Transplantation 2021 cited by 77

  16. Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

    Authors: Peter Dreger, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Wagner, Gerald Wulf, Reinhardt Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glaß, Claudia D. Baldus, Vladan Vučinić, Dimitrios Mougiakakos, Max S. Topp, Roland Schroers, Daniel Wolff, Simone Thomas, Nicolaus Kröger, Wolfgang Bethge, on behalf of the German Lymphoma Alliance (GLA), the German Stem Cell Transplantation Registry (DRST) - Bone Marrow Transplantation 2022 cited by 49

  17. Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)

    Authors: Susanne Hofmann, Maria‐Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt - Journal of Clinical Medicine 2019 cited by 108

  18. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

    Authors: Maria‐Luisa Schubert, Anita Schmitt, Angela Hückelhoven‐Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp‐Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas E. Kulozik, Joachim B. Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann W. Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt - Journal of Hematology & Oncology 2023 cited by 36

  19. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Authors: Nicolaus Kröger, Ernst Holler, Guido Kobbe, Martin Bornhäuser, Rainer Schwerdtfeger, H. Baurmann, Arnon Nagler, Wolfgang Bethge, Matthias Stelljes, Lutz Uharek, Hannes Wandt, Andreas Burchert, Paolo Corradini, Jörg Schubert, Martin Kaufmann, Peter Dreger, Gerald Wulf, Hermann Einsele, Tatjana Zabelina, Hans Michael Kvasnicka, Jürgen Thiele, Ronald Brand, Axel R. Zander, Dietger Niederwieser, Theo M. de Witte - Blood 2009 cited by 394

  20. Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

    Authors: Dietrich W. Beelen, Matthias Stelljes, Péter Reményi, Eva‐Maria Wagner‐Drouet, Peter Dreger, Wolfgang Bethge, Fabio Ciceri, Friedrich Stölzel, Christian Junghanß, Hélène Labussière‐Wallet, Kerstin Schaefer‐Eckart, Goetz Ulrich Grigoleit, Christof Scheid, Francesca Patriarca, Alessandro Rambaldi, Dietger Niederwieser, Inken Hilgendorf, Domenico Russo, Gèrard Socié, Ernst Holler, Bertram Glaß, Jochen Casper, Gerald Wulf, Nadežda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Ursula La Rocca, Jürgen Finke, Fabio Benedetti, Uwe Pichlmeier, Anja Klein, Joachim Baumgart, Mirosław Markiewicz - American Journal of Hematology 2022 cited by 61

  21. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients

    Authors: Thomas Luft, Clemens‐Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, Lars Kihm, Matthias Bauer, Peter Dreger, Uta Merle - Frontiers in Immunology 2021 cited by 61

  22. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

    Authors: Rishika Prasad, Abdur Rehman, Lubna Rehman, Faezeh Darbaniyan, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Eli Zamir, Sabine Schmidt, Tomo Hayase, Chia‐Chi Chang, Lauren K. McDaniel, Ivonne I. Flores, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Michael Wang, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Joel Turner, Fareed Khawaja, Ranran Wu, Jennifer B. Dennison, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Marco L. Davila, Peter Dreger, Felix Korell, Anita Schmitt, Mark R. Tanner, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Samir Hanash, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Johannes F. Fahrmann, Christoph K. Stein‐Thoeringer, Eran Elinav, Michael D. Jain, Eiko Hayase, Robert R. Jenq, Neeraj Saini - Blood 2024 cited by 50

  23. EASIX for prediction of survival in lower-risk myelodysplastic syndromes

    Authors: Almuth Maria Anni Merz, Ulrich Germing, Guido Kobbe, Jennifer Kaivers, Anna Jauch, Aleksandar Radujkovic, Manuela Hummel, Axel Benner, Maximilian Merz, Peter Dreger, Thomas Luft - Blood Cancer Journal 2019 cited by 69

  24. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Authors: Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus A. Weigand, Christian Nußhag, Lars Bullinger, Jens Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria J. G. T. Vehreschild, Stefan Schmiedel, Marylyn M. Addo, Felix Herth, Michael Kreuter, Phil‐Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl Christoph Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried V. Kern, Anita Schmitt, Hanns‐Martin Lorenz, Margarida Souto‐Carneiro, Mary Gaeddert, Niels Halama, Stefan Meuer, Hans‐Georg Kräusslich, Bárbara Müller, Paul Schnitzler, Sylvia Parthé, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Michael Schmitt, Peter Dreger, Katharina Kriegsmann, Richard F. Schlenk, Carsten Müller‐Tidow - Nature Cancer 2022 cited by 62